The authors used a quantitative PCR (qPCR) analysis of biopsy cores representing Grade I–IV astrocytomas to demonstrate the significantly higher expression of SHC4 in tumor tissue compared to benign tissue [24,25]. The gene discussed is SHC4; the disease is astrocytoma (excluding glioblastoma).